Berlin, Halle, 16.03.2023: Since January of this year, the project "Zielwirk" is developing a new chitosan technology for the efficient release of mRNA active ingredients. The technology aims to ensure that drugs for the treatment of serious diseases can be better absorbed as well as processed by the body. The participating project partners Heppe Medical Chitosan GmbH, FDX Fluid Dynamix GmbH, Martin Luther University Halle-Wittenberg and the Fraunhofer Institute for Production Systems and Design Technology (IPK) are funded by the German Federal Ministry of Economics and Climate Protection (BMWK) with six million euros over three years.

On November 16, 2022 the supporting association of the new cluster initiative Life-Science Saxony-Anhalt was founded in the technology park Weinberg Campus. We, the Heppe Medical Chitosan GmbH, are excited to be part of it as a founding member.

The High-Tech Gründerfonds invests in Heppe Medical Chitosan GmbH, a developer and manufacturer of high purity biopolymers and nanoparticulate materials on chitin and chitosan basis.